Category Specific RSS

Satire

Cosmetic surgeon relieved to avoid executing Plan B on Patrick Cripps

Carlton fans breathed a sigh of relief on Thursday night when captain Patrick Cripps had his 2-match suspension overturned on appeal, but none will be more relieved than cosmetic surgeon Dr Hugh Honey who was on standby to perform rapid reconstructive surgery if the appeal failed. 

Also relieved will likely be Carlton disappointment Paddy Dow who is believed to have been stashed away in a safe house for several days in the event Honey had to perform reconstructive surgery on Cripps in order for him to play on the weekend, as Dow. 

“Having assessed all legal options, we thought outside the box and were ready to go with the Dow augmentation if the appeal failed,” said Dr Honey. 

“It would have put me under a lot of pressure to perform the procedure, but Dow was selected as the lookalike on the basis no one else would have believed Patrick to be any other player.

“While Paddy has been struggling to break into the side, Carlton’s insistence that he was go good that we should draft him ahead of Luke Davies-Uniacke, Aaron Naughton and Tim Kelly, would have been vindicated if he put up a Cripps-like performance to secure Carlton a spot in the Finals.”

“Plus, Paddy, Patty… Same thing!”

In the event that Cripps did not wish to proceed with the surgery, Plan C was to just have Dow beaten up in a public dispute and play on Saturday heavily bandaged beyond recognition in an act of heroic bravery.

Elias Pivep

Failed stand-up comic who now gets his kicks from Simpsons business memes.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago